Sweden· SE-20040302000128
ADVATE 250 IE (5 ml) Pulver och vätska till injektionsvätska, lösning
A medicinal product containing octocog alfa, registered in Sweden by Takeda Manufacturing Austria AG.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Octocog Alfa
- Manufacturer
- Takeda Manufacturing Austria AG
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20040302000128
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Octocog alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumAdvate 250 IUTakeda Manufacturing Austria
- SpainADVATE 250 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLETakeda Manufacturing Austria Ag
- FinlandHelixate NexgenBayer AG
- NorwayAdvateTakeda Manufacturing Austria AG
- SwitzerlandAdvate 250 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer InjektionslösungTakeda Pharma AG
- CzechiaADVATETakeda Manufacturing Austria AG, Vídeň
- United KingdomAdvate 1,000unit powder and solvent for solution for injection vialsTakeda UK Ltd
- IrelandAdvate 1000 IU/2 ml powder and solvent for solution for injectionTakeda Manufacturing Austria AG
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Recombinate
- Iceland · Advate, Kovaltry
- Italy · Recombinate
- Liechtenstein · Advate, Kovaltry
- Lithuania · Recombinate
- Netherlands · Recombinate
- Norway · Advate, Kovaltry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7f636cc-f5c2-4cf9-82c0-8db882018e94 GET /v1/drugs/d7f636cc-f5c2-4cf9-82c0-8db882018e94?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20040302000128",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20040302000128",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/advate"
}See everything about octocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.